StonvexLoading…
StonvexStonvexStonvexCore line items from IMRN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-06-30 | Annual 2024 2024-06-30 | Annual 2023 2023-06-30 | Annual 2022 2022-06-30 |
|---|---|---|---|---|
Revenue | A$7.29M | A$4.90M | A$1.80M | A$765.19K |
Operating Income | A$-5.34M | A$-5.80M | A$-3.57M | A$-2.87M |
Net Income | A$-5.22M | A$-6.94M | A$-3.79M | A$-2.85M |
EPS (Diluted) | A$-2.26 | A$-3.04 | A$-1.66 | A$-1.25 |
Total Assets | A$10.13M | A$15.55M | A$21.99M | A$24.86M |
Total Liabilities | A$2.06M | A$2.84M | A$2.37M | A$1.68M |
Cash & Equivalents | A$2.83M | A$11.66M | A$17.16M | A$22.11M |
Free Cash Flow OCF − CapEx | Not available | A$-5.88M | A$-2.60M | A$-3.16M |
Shares Outstanding | 233.96M | 228.00M | 17.5 | 227.80M |